North Crest Asset Manangement, LLC Lexa Gene Holdings Inc. Transaction History

North Crest Asset Manangement, LLC

  • $3.19 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$0.1 - $0.21 $4,300 - $9,030
43,000 Added 49.43%
130,000 $14,000
Q3 2022

Oct 17, 2022
BUY
$0.08 - $0.15 $2,880 - $5,400
36,000 Added 70.59%
87,000 $9,000
Q2 2022

Jul 18, 2022
BUY
$0.11 - $0.18 $3,135 - $5,130
28,500 Added 126.67%
51,000 $6,000
Q1 2022

Apr 18, 2022
BUY
$0.16 - $0.32 $3,600 - $7,200
22,500 New
22,500 $4,000

Others Institutions Holding LXXGF

# of Institutions
4
Shares Held
406K
Call Options Held
0
Put Options Held
0
View Full List

About LexaGene Holdings Inc.

LXXGF Quotes by TradingView
  • Ticker LXXGF
  • Exchange OTC
  • Description
  • LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life science...
More about LXXGF
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email